FIELD: medicine.
SUBSTANCE: composition comprises gel-forming matrix having one or more active ingredients with prolonged release time of one or more active substances under gastrointestinal tract fluids action. Hydroxypropylmethyl cellulose of high or moderate viscosity or hydroxyethyl cellulose of high or moderate viscosity are available in the composition in 1:0.85-1:1.2 proportion, respectively. The composition optionally comprises also hydroxypropylmethyl cellulose of low viscosity with hydroxypropylmethyl cellulose of low viscosity to one of high or moderate viscosity proportion being equal to 1:0.01-1.0.2, respectively. The composition essentially does not depend on ionic force of dissolving medium habitual for gastrointestinal tract fluids as norm even if the composition is not enclosed into coating shell.
EFFECT: enhanced effectiveness of treatment.
12 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION AT DELAYED RELEASE OF PHARMACEUTICALLY ACTIVE SUBSTANCE AND METHOD FOR RELEASING PHARMACEUTICALLY ACTIVE SUBSTANCE | 1999 |
|
RU2259826C2 |
MODIFIED RELEASE THERAPEUTIC SYSTEMS FOR ORAL ADMINISTRATION OF CURCUMIN IN TREATING INTESTINAL DISORDERS | 2014 |
|
RU2692473C1 |
FLUVASTATIN CONTAINING PHARMACEUTICAL COMPOSITIONS | 2001 |
|
RU2297223C2 |
PROLONGED LIQUID DOSAGE FORM OF BISCHOFITE | 2011 |
|
RU2455008C1 |
CARVEDILOL HYDROPHILIC MOLECULAR DISPERSED SOLUTION | 2001 |
|
RU2248204C2 |
LAMOTRIGINE-BASED COMPOSITIONS OF PROLONGED RELEASE | 2003 |
|
RU2325163C2 |
WATER-SOLUBLE LOW-SUBSTITUTED HYDROXYETHYL CELLULOSE, DERIVATIVES THEREOF, PREPARATION METHOD THEREOF AND USE | 2006 |
|
RU2415160C2 |
MODIFIED-RELEASE THERAPEUTIC SYSTEMS FOR ORAL ADMINISTRATION OF MENTHOL IN THE TREATMENT OF INTESTINAL DISORDERS | 2014 |
|
RU2683645C1 |
PHARMACEUTICAL PREPARATION WITH MODIFIED ELUTION | 2003 |
|
RU2352323C2 |
PARKINSON'S DISEASE THERAPY WITH APPLICATION OF COMBINATION WITH FIXED DOSES | 2013 |
|
RU2642962C9 |
Authors
Dates
2006-10-20—Published
2001-09-28—Filed